Primary Record
Talampanel
- In stock
- 669 g
- Purity
- 99.2 %
- CAS
- 161832-65-1
Compound Identifiers & Properties
- CAS
- 161832-65-1
- PubChem CID
- 164509
- SMILES
- C[C@@H]1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3
- Canonical SMILES
- CC(=O)N1N=C(c2ccc(N)cc2)c2cc3c(cc2C[C@H]1C)OCO3
Names & Synonyms
- Talampanel
- Ampanel
- Kinampa
- (-)-Talampanel
- 161832-65-1
- talampanelum
- Talampanel (INN)
- Talampanel [INN]
- talampanel(ly300164)
- GYKI 53773
- AC1L4UWP
- CVS43XG1L5
- Gyki 53405
- TALAMPANEL [MI]
- UNII-CVS43XG1L5
- GYKI-53773
- AC1Q5KPR
- RefChem:187215
- TALAMPANEL [USAN]
- D08BEO
- LY-300164
- Talampanel (GYKI 53773)
- Talampanel (LY300164)
- LY 300164
- CHEMBL61872
- LY300164
- SCHEMBL118011
- DTXSID10167259
- GTPL8279
- orb1307705
- DTXCID7089750
- SCHEMBL30272868
- Talampanel, >=97% (HPLC)
- CHEBI:34992
- CTK4D0975
- GYKI53773
- AOB5775
- IDR-53773
- JACAAXNEHGBPOQ-LLVKDONJSA-N
- MFCD00871406
- C19H19N3O3
- GLXC-06006
- KST-1A2491
- EX-A1569
- GYKI 537773
- ZINC3823565
- AR-1A7825
- CID164509
- HB0600
- NSC729898
- AKOS024458464
- C19-H19-N3-O3
- ACN-039810
- CS-5225
- DB04982
- NSC-729898
- GYKI-53773;LY-300164
- 1-[(8R)-5-(4-aminophenyl)-8-methyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-7-yl]ethanone
- NCGC00387224-01
- NCGC00387224-02
- AC-35959
- AN-31248
- BC282779
- HY-15079
- LS-62670
- MS-25120
- (8R)-7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine
- C13670
- J722.092H
- B5824
- NS00069335
- T-185
- Talampanel, GYKI-53773; LY-300164
- A15515
- C14993
- D02696
- 832T651
- A948685
- (R)-(-)-1-(4-Aminophenyl)-3-acetyl-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine
- 7H-1,3-Dioxolo[4,5-h][2,3]benzodiazepine,7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-, (8R)-
- Q7678869
- (R)-7-acetyl-5-(p-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine
- BRD-K80359953-001-01-3
- BRD-K80359953-001-02-1
- (R)-7-Acetyl-5-(p-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo(4,5-h)(2,3)benzodiazepine
- 7H-1,3-Dioxolo(4,5-h)(2,3)benzodiazepine, 7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-, (8R)-
- (8R)-7-acetyl-5-(4-aminophenyl)-8,3-dioxolo[4,5-h][2,3]benzodiazepine
- (R)-7-acetyl-5-(p-aminophenyl)-8,3-dioxolo[4,5-h][2,3]benzodiazepine
- 198904-00-6
- 7H-1,3-Dioxolo(4,5-h)(2,3)benzodiazepine, 7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-, (R)-
- 7H-1,3-Dioxolo(4,5-h)(2,3)benzodiazepine, 8,9-dihydro-7-acetyl-5-(4-aminophenyl)-8-methyl-, (R)-
- (R)-7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo(4,5-h)benzodiazepine
- 1-(4'-aminophenyl)-3-acetyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine
- 7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo(4,5-h)benzodiazepine
- (8R)-7-Acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]-benzodiazepine
- (R)-1-(5-(4-aminophenyl)-8-methyl-8,9-dihydro-7H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d][1,2]diazepin-7-yl)ethan-1-one
- (R)-1-(5-(4-aminophenyl)-8-methyl-8,9-dihydro-7H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d][1,2]diazepin-7-yl)ethanone
- (R)-7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine
- 1-((8R)-5-(4-Aminophenyl)-8-methyl-8,9-dihydro-(1,3)dioxolo(4,5-h)(2,3)benzodiazepin-7-yl)ethanone
- 1-(4-Aminophenyl)-3-acetyl-4alpha-methyl-7,8-(methylenedioxy)-4,5-dihydro-3H-2,3-benzodiazepine
- 1-[(13R)-10-(4-aminophenyl)-13-methyl-4,6-dioxa-11,12-diazatricyclo[7.5.0.03,7]tetradeca-1,3(7),8,10-tetraen-12-yl]ethan-1-one
- 1-[(8R)-5-(4-aminophenyl)-8-methyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-7-yl]ethanone.
- 1-[(8R)-5-(4-Aminophenyl)-8-methyl-8,9-dihydro-2H,7H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-7-yl]ethan-1-one
- 1-[[1-(4-Aminophenyl)-7,8-(methylenedioxy)-4,5-dihydro-4alpha-methyl-3H-2,3-benzodiazepin]-3-yl]ethanone
- 7H-1,3-Dioxolo[4,5-h][2,3]benzodiazepine, 7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-, (8R)-
- R-(-)-1-(4-aminophenyl)-3-acetyl-4-methyl-7,8-methylenedioxy-3,4-dihydro-5H-2,3-benzodiazepine